Mahallawi W. Novel bivalent mucosal antigen formulation targeting SARS-CoV-2 and influenza: immunogenicity assessment using zan in vitro human nasal-associated lymphoid tissue model. pjvs [Internet]. 2026 Jun. 15 [cited 2026 Aug. 15];29(2):281–289. Available from: https://wydawnictwo.pan.pl/index.php/pjvs/article/view/1273